Answers are grounded in this paper and cite their sources.
In October 2007 the first epothilone derivative has received FDA approval for the treatment of metastatic breast cancer. This event forms the background of this review which tries to highlight the historical development of the epothilones, namely their discovery, biosynthesis, fermentation, total synthesis, semisynthetic derivatives and clinical trials.
No takes yet. Share an insight, caveat, or question.
Mulzer et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: